<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2025.1617614</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Genomic features and fitness cost of co-existence of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> plasmids in ICU-derived pan-drug resistant <italic>Pseudomonas aeruginosa</italic>
</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" corresp="yes">
<name>
<surname>Zheng</surname>
<given-names>Lin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1013107/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Wang</surname>
<given-names>Zixian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Xin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Gejin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jing</surname>
<given-names>Jie</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Shiwen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ji</surname>
<given-names>Xue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jiang</surname>
<given-names>Bowen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhu</surname>
<given-names>Lingwei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Guo</surname>
<given-names>Xuejun</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/396919/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Key Laboratory of Jilin Province for Zoonosis Prevention and Control, Changchun Veterinary Research Institute, Chinese Academy of Agriculture Sciences</institution>, <addr-line>Changchun, Jilin</addr-line>,&#xa0;<country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>China-Japan Union Hospital, Jilin University</institution>, <addr-line>Changchun, Jilin</addr-line>,&#xa0;<country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Valerio Baldelli, University of Milan, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Dao-Feng Zhang, Hohai University, China</p>
<p>Rhishita Chourashi, University of Maryland, United States</p>
<p>Shijun Sun, First Affiliated Hospital of Zhengzhou University, China</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Lin Zheng, <email xlink:href="mailto:zl050514@163.com">zl050514@163.com</email>; Lingwei Zhu, <email xlink:href="mailto:lingweiz@126.com">lingweiz@126.com</email>; Xuejun Guo, <email xlink:href="mailto:xuejung2021@163.com">xuejung2021@163.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>08</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>15</volume>
<elocation-id>1617614</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>07</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Zheng, Wang, Zhang, Lu, Jing, Sun, Sun, Ji, Jiang, Zhu and Guo.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Zheng, Wang, Zhang, Lu, Jing, Sun, Sun, Ji, Jiang, Zhu and Guo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Backgroud</title>
<p>The emergence of carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> (CRPA) co-producing KPC-2 and VIM-2 has increased the healthcare threats.</p>
</sec>
<sec>
<title>Results</title>
<p>In this study, a CRPA strain 18102011, was isolated from the bile of a burn patient in ICU of China. Its whole genome was sequenced via the PacBio platform. The molecular characteristics of the genome were analyzed to assess the genetic environment of the carbapenemase genes <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub>. Antimicrobial susceptibility, plasmid stability, bacterial growth curves, and plasmid conjugation were measured. Strain 18102011 exhibited a resistant pattern to all 23 antibiotics tested, which could be defined as a pan-drug resistant <italic>P. aeruginosa</italic> strain. Two plasmids were identified in this strain: the Inc<sub>pRBL16</sub> mega-plasmid pP2011&#x2013;1 carrying <italic>bla</italic>
<sub>VIM-2</sub> and the IncP6 plasmid pP2011&#x2013;2 carrying <italic>bla</italic>
<sub>KPC-2</sub>. <italic>bla</italic>
<sub>VIM-2</sub> was located in the region of In2057 (a novel class 1 integron) that was inserted into pP2011-1, and the expression of the <italic>bla</italic>
<sub>VIM-2</sub> gene was increased by the PcW<sub>TGN-10</sub> promoter located at the 5&#x2019;-CS. For the <italic>bla</italic>
<sub>KPC-2</sub> gene, the core module Tn<italic>3</italic>-IS<italic>Kpn27</italic>-<italic>bla</italic>
<sub>KPC</sub>-&#x394;IS<italic>Kpn6</italic> served as the <italic>bla</italic>
<sub>KPC-2</sub> platform in pP2011-2, and the expression of the <italic>bla</italic>
<sub>KPC-2</sub> gene was achieved via the P1 promoter located downstream of IS<italic>Kpn27</italic>. This expression pattern resulted in MICs of 4,096 &#x3bc;g/mL of imipenem for both strain 18102011 and its transconjugant D2011. Both plasmids were stable in strain 18102011 and could be co-transferred to other strains.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>This study raised concerns regarding the high stability and non-inferior fitness of <italic>bla</italic>
<sub>KPC-2</sub>-<italic>bla</italic>
<sub>VIM-2</sub>-CRPA, shed light on its genomic characteristics, and underscored the importance of continued surveillance of CRPA.</p>
</sec>
</abstract>
<kwd-group>
<kwd>carbapenem-resistant <italic>Pseudomonas aeruginosa</italic>
</kwd>
<kwd>blaKPC-2</kwd>
<kwd>blaVIM-2</kwd>
<kwd>plasmid</kwd>
<kwd>fitness cost</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="2"/>
<ref-count count="48"/>
<page-count count="11"/>
<word-count count="5546"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Antibiotic Resistance and New Antimicrobial drugs</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>
<italic>Pseudomonas aeruginosa</italic> accounts for 10-15% of nosocomial infections worldwide (<xref ref-type="bibr" rid="B3">Blanc et&#xa0;al., 1998</xref>). It can attach to the surfaces of medical instruments through biofilm formation, facilitating its spread within hospitals, particularly in the ICU (<xref ref-type="bibr" rid="B10">Cornaglia et&#xa0;al., 2000</xref>; <xref ref-type="bibr" rid="B26">Li et&#xa0;al., 2022</xref>). Most ICU patients use broad-spectrum antimicrobials to treat bacterial infections, and the prolonged use of antibiotics to eradicate bacterial infections is commonly practiced (<xref ref-type="bibr" rid="B34">Pang et&#xa0;al., 2019</xref>). However, the acquisition of antibiotic resistance genes by mobile genetic elements (e.g., plasmids, transposons, integrative elements, and conjugative elements), combined with their transfer among bacterial strains, leads to the development of multidrug-resistant <italic>P. aeruginosa</italic> strains in patients (<xref ref-type="bibr" rid="B13">De Vos et&#xa0;al., 1997</xref>; <xref ref-type="bibr" rid="B35">Partridge et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B6">Botelho et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B2">Allameh et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B29">Mohammadnejad et&#xa0;al., 2023</xref>). Such infections are associated with high mortality rates, ranging from 18 to 61% (<xref ref-type="bibr" rid="B24">Kang et&#xa0;al., 2003</xref>). Although carbapenems are the most important antibiotics for treating their <italic>P. aeruginosa</italic> infections, the bacteria can be resistant to them due in part to the acquisition of carbapenemase genes, complicating treatment (<xref ref-type="bibr" rid="B35">Partridge et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B6">Botelho et&#xa0;al., 2019</xref>). Some strains even exhibit pan-drug resistance, rendering subsequent treatments with drugs such as colistin and amikacin ineffective, which creates a therapeutic dilemma. Consequently, antimicrobial resistance has become a global health challenge that threatens many medical achievements of the last century and causing serious harm to health system outcomes.</p>
<p>In this study, <italic>P. aeruginosa</italic> strain 18102011 was isolated from the bile of a burn patient in a hospital ICU in 2018 (Changchun, China). The strain was genetically investigated to evaluate the genetic mechanism of its drug resistance. The whole-genome sequence of the strain was generated, and its molecular characteristics were subsequently investigated. The strain belonged to multi-locus sequence typing (ST2374) and serotype O4. Furthermore, the strain co-harbored the <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes, enabling it to resist carbapenems. The MICs of imipenem and meropenem (carbapenem) were both &gt;256 &#x3bc;g/mL. Additionally, it was a pan-drug resistant <italic>P. aeruginosa</italic> that was resistant to 23 antibiotics, including amikacin, colistin, and fosfomycin. Further genetic analyses were applied to the plasmids pP2011&#x2013;1 carrying <italic>bla</italic>
<sub>VIM-2,</sub> and pP2011&#x2013;2 carrying <italic>bla</italic>
<sub>KPC-2</sub> to characterize their genetic environments. The transcriptional expression of resistance genes <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> changed after imipenem exposure. Moreover, the fitness cost, loss of resistance genes under serially passage, and horizontal transmission ability of the <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes in bacteria were analyzed. These results provide a deeper understanding of the acquisition of drug resistance genes in <italic>P. aeruginosa</italic>.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Identification of <italic>bla</italic>
<sub>KPC-2</sub>-<italic>bla</italic>
<sub>VIM-2</sub>-CRPA</title>
<p>A CRPA obtained from bile collected from a patient in the intensive care unit (ICU) of a public Chinese hospital in 2018, exhibited resistance to both imipenem and meropenem. This isolate was forwarded to our laboratory for species identification and antimicrobial susceptibility testing via the BD Phoenix-100 system, using <italic>Escherichia coli</italic> ATCC25922 as the quality control for susceptibility testing (The antibiotics tested were shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>). Additionally, the isolate was stored at -80&#xb0;C for potential future use. The experimental protocols were approved by the Ethics Committee of the Jilin University (JDKQ202316EC).</p>
<p>To ensure the accuracy of our findings, the MICs of imipenem and meropenem were determined by E-test. Furthermore, the MICs for other antibiotics that have not been tested in the BD Phoenix-100 system, such as colistin, ceftazidime-avibactam, and fosfomycin, which were commonly used to treat carbapenem-resistant bacteria, were also ascertained using E-test (The antibiotics tested were shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S2</bold>
</xref>). And the quality control strain was <italic>E. coli</italic> ATCC25922. Drug-resistance levels, including resistance, intermediary, and sensitivity thresholds, were assessed by the guidelines established by the Clinical and Laboratory Standards Institute.</p>
<p>It was subject to polymerase chain reaction (PCR) and Sanger sequencing and targets the <italic>oprL</italic> gene (which was specific to <italic>P. aeruginosa</italic>), which encoded a peptidoglycan-associated lipoprotein (<xref ref-type="bibr" rid="B13">De Vos et&#xa0;al., 1997</xref>). Additionally, PCR assays were performed to detect the presence of carbapenemase genes, including <italic>bla</italic>
<sub>IMP</sub>, <italic>bla</italic>
<sub>SPM</sub>, <italic>bla</italic>
<sub>AIM</sub>, <italic>bla</italic>
<sub>VIM</sub>, <italic>bla</italic>
<sub>GIM</sub>, <italic>bla</italic>
<sub>BIC</sub>, <italic>bla</italic>
<sub>SIM</sub>, <italic>bla</italic>
<sub>NDM</sub>, <italic>bla</italic>
<sub>DIM</sub>, <italic>bla</italic>
<sub>KPC</sub> and <italic>bla</italic>
<sub>OXA-48</sub> (<xref ref-type="bibr" rid="B36">Poirel et&#xa0;al., 2011</xref>) (The primer sequences and PCR conditions were listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S3</bold>
</xref>).</p>
</sec>
<sec id="s2_2">
<title>Sequencing and genome sequence assembly</title>
<p>Bacterial genomic DNA was isolated using the UltraClean microbial DNA extraction kit (Qiagen, Germany) and sequenced via a PacBio RS II sequencer (Pacific Biosciences, USA). The sequence reads were <italic>de novo</italic> assembled using the SMARTdenovo assembler (<ext-link ext-link-type="uri" xlink:href="http://github.com/ruanjue/smartdenovo">http://github.com/ruanjue/smartdenovo</ext-link>). The assembly results were corrected based on sequencing data through three rounds of error correction by using the Racon software (version 1.4.13). Subsequently, three rounds of error correction were performed using the Pilon software (version 1.22) with second-generation reads, yielding the final assembly results.</p>
</sec>
<sec id="s2_3">
<title>Genome annotation and comparison</title>
<p>Precise bacterial species identification was evaluated using pair-wise ANI (<ext-link ext-link-type="uri" xlink:href="http://www.ezbiocloud.net/tools/ani">http://www.ezbiocloud.net/tools/ani</ext-link>) analysis between the genomes generated in this study and the <italic>P. aeruginosa</italic> reference genome sequence PAO1 (GenBank ID: NC_002516.2). A &#x2265;95% ANI cut-off was used to define bacterial species (<xref ref-type="bibr" rid="B47">Yoon et&#xa0;al., 2017</xref>). The PAst (<ext-link ext-link-type="uri" xlink:href="https://cge.food.dtu.dk/services/PAst/">https://cge.food.dtu.dk/services/PAst/</ext-link>) server was used to perform O-antigen classification. In addition, <italic>RAST 2.0</italic> (<xref ref-type="bibr" rid="B7">Brettin et&#xa0;al., 2015</xref>) and <italic>BLASTP</italic>/<italic>BLASTN</italic> (<xref ref-type="bibr" rid="B4">Boratyn et&#xa0;al., 2013</xref>) searches were used to predict open reading frames (ORFs), whereas comparisons with the ResFinder 4.0 (<xref ref-type="bibr" rid="B5">Bortolaia et&#xa0;al., 2020</xref>) (<ext-link ext-link-type="uri" xlink:href="https://cge.cbs.dtu.dk/services/ResFinder/">https://cge.cbs.dtu.dk/services/ResFinder/</ext-link>), CARD (<ext-link ext-link-type="uri" xlink:href="https://card.mcmaster.ca">https://card.mcmaster.ca</ext-link>) (<xref ref-type="bibr" rid="B1">Alcock et&#xa0;al., 2023</xref>) and VFDB (<xref ref-type="bibr" rid="B28">Liu et&#xa0;al., 2022</xref>) (<ext-link ext-link-type="uri" xlink:href="http://www.mgc.ac.cn/VFs/">http://www.mgc.ac.cn/VFs/</ext-link>) databases were used to identify acquired resistance genes and virulence genes. In addition, the ISfinder (<xref ref-type="bibr" rid="B44">Varani et&#xa0;al., 2011</xref>) (<ext-link ext-link-type="uri" xlink:href="https://www-is.biotoul.fr/">https://www-is.biotoul.fr/</ext-link>; Lastest Database Update 2021-9-21), TnCentral (<ext-link ext-link-type="uri" xlink:href="https://tncentral.ncc.unesp.br">https://tncentral.ncc.unesp.br</ext-link>), INTEGRAL (<xref ref-type="bibr" rid="B31">Moura et&#xa0;al., 2009</xref>) (<ext-link ext-link-type="uri" xlink:href="http://integrall.bio.ua.pt/">http://integrall.bio.ua.pt/</ext-link>), and ICEberg 2.0 (<xref ref-type="bibr" rid="B27">Liu et&#xa0;al., 2019</xref>) (<ext-link ext-link-type="uri" xlink:href="http://db-mml.sjtu.edu.cn/ICEberg/">http://db-mml.sjtu.edu.cn/ICEberg/</ext-link>) platforms were used to identify mobile elements. The online database BPROM (<xref ref-type="bibr" rid="B8">Cassiano and Silva-Rocha, 2020</xref>) was used for promoter prediction. Pairwise sequence comparisons were conducted using <italic>BLASTN</italic> searches. Functional analysis of proteins in families and domain prediction was conducted using the InterPro (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/interpro">https://www.ebi.ac.uk/interpro</ext-link>) database. Gene organization diagrams were drawn in Inkscape 1.0 (<ext-link ext-link-type="uri" xlink:href="http://inkscape.org/en/">http://inkscape.org/en/</ext-link>).</p>
<p>Multilocus sequence typing (ST) was conducted by evaluating gene sequence data (including seven conserved housekeeping genes: <italic>acsA</italic>, <italic>aroE</italic>, <italic>gtaA</italic>, <italic>mutL</italic>, <italic>nuoD</italic>, <italic>ppsA</italic>, and <italic>trpE</italic>) with the pubMLST platform (<ext-link ext-link-type="uri" xlink:href="https://pubmlst.org/">https://pubmlst.org/</ext-link>).</p>
</sec>
<sec id="s2_4">
<title>Conjugation experiments</title>
<p>Plasmid transferability was tested using <italic>E. coli</italic> EC600 (rifampicin resistant) and strain 18102011 as the recipient strain and donor strain, respectively. Both the donor and recipient strains were cultured separately overnight at 37&#xb0;C. Adjust the bacterial concentrations of both recipient strain EC600 and the donor strain 18102011 to 10<sup>9</sup> CFU/mL. The donor and recipient strains were then subsequently mixed at a 1:1 ratio. The mixture was then spotted onto a 1cm<sup>2</sup> hydrophilic nylon membrane filter (Millipore; 0.45 &#xb5;m pore size), which was placed on an LB agar plate and incubated at 37&#xb0;C for 6 h to initiate mating. After incubation, cells were recovered from the filter and serially diluted from 10&#x2013;<sup>1</sup> to 10<sup>-9</sup>, with three parallel replicates per dilution. The dilution was spotted onto LB agar (containing 80 &#xb5;g/mL rifampicin and 4 &#xb5;g/mL imipenem) and LB agar (containing 80 &#xb5;g/mL rifampicin) to select the carbapenem-resistant <italic>E. coli</italic> transconjugants and recipient strain <italic>E. coli</italic> EC600, respectively. The entire experimental procedure was repeated three times. The conjugation transfer efficiency between strain 18102011 and EC600 was calculated using the <xref ref-type="disp-formula" rid="eq1">
<bold>Equation (1.1)</bold>
</xref>. Antimicrobial susceptibility of transconjugants was determined using the BD Phoenix-100 system, while the MIC of imipenem for both strain 18102011 and its transconjugant D2011 was determined by the broth dilution method.</p>
<disp-formula id="eq1">
<label>(1.1)</label>
<mml:math display="block" id="M1">
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>C</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>j</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>s</mml:mi>
<mml:mi>f</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>e</mml:mi>
<mml:mi>f</mml:mi>
<mml:mi>f</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>y</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>=</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>e</mml:mi>
<mml:mi>x</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>j</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>s</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>C</mml:mi>
<mml:mi>F</mml:mi>
<mml:mi>U</mml:mi>
</mml:mstyle>
<mml:mo stretchy="false">/</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>m</mml:mi>
<mml:mi>L</mml:mi>
</mml:mstyle>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>N</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>m</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>o</mml:mi>
<mml:mi>f</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>p</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>b</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>c</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>a</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mrow>
<mml:mo stretchy="false">(</mml:mo>
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>C</mml:mi>
<mml:mi>F</mml:mi>
<mml:mi>U</mml:mi>
</mml:mstyle>
<mml:mo stretchy="false">/</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>m</mml:mi>
<mml:mi>L</mml:mi>
</mml:mstyle>
</mml:mrow>
<mml:mo stretchy="false">)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
</sec>
<sec id="s2_5">
<title>Bacterial growth curve assay</title>
<p>In studies assessing plasmid fitness burden, it&#x2019;s standard and scientifically appropriate to compare an isogenic pair. To specifically determine the fitness cost associated with the presence of plasmids harboring <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes in strain 18102011, bacterial growth curves were constructed for both transconjugant D2011 (carrying <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub>) of strain 18102011 and recipient strain <italic>E. coli</italic> EC600. The overnight culture of strain D2011 and EC600 were diluted to 0.5 McFarland standard and subsequently diluted 1:100 in antibiotic-free LB broth. Over the next 12 hours, the optical density (OD<sub>600</sub>) of each culture was monitored at 2-hour intervals via a NanoPhotometer N60 (Implen, Germany). The data represent the mean &#xb1; SEM of two independent experiments. Statistical differences were determined by two-tailed <italic>t</italic>-test (*<italic>p&lt;</italic> 0.05).</p>
</sec>
<sec id="s2_6">
<title>Plasmid stability testing</title>
<p>Strain 18102011 was grown at 37&#xb0;C in a shaking incubator set to 200 rpm and serially passaged for 10 days, with each passage diluted 1:500 in antibiotic-free LB broth. After 5 and 10 days, the cultures were serially diluted and plated on antibiotic-free LB agar. Fifty single colonies were randomly selected for detection of the <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes by PCR on the 5<sup>th</sup> and 10<sup>th</sup> day, respectively, and were used as markers to reflect the loss of their plasmid. The data represent the mean &#xb1; SEM of two independent experiments. Statistical differences were determined by two-tailed <italic>t</italic>-test (*<italic>p&lt;</italic> 0.05).</p>
</sec>
<sec id="s2_7">
<title>RNA preparation and transcriptome sequencing</title>
<p>Bacterial genomic RNA (before and after the addition of imipenem) was isolated using the RNAprep Pure Cell/Bacteria Kit RNAprep Pure (TianGen, China). Starting with total RNA, the mRNA was purified by rRNA depletion. And cDNA libraries were constructed using mRNA. Transcriptome sequencing was performed on triplicate samples, which was carried out by Illumina NovaSeq. Using HTSeq v0.6.1, the number of reads mapped to each gene was counted. FPKM values for each gene were then calculated based on gene length and the corresponding read counts. FPKM, which stands for Fragments Per Kilobase of transcript sequence per Million base pairs sequenced, accounts for both sequencing depth and gene length, making it a widely used method for estimating gene expression levels. The DESeq R package (1.18.0) was employed to determine differential expression of strain 18102011 carrying plasmids before and after the addition of imipenem, using a model based on the negative binomial distribution. Using the <xref ref-type="disp-formula" rid="eq2">Equstion (1.2)</xref>, we calculate the fold change in expression levels of the resistance genes (<italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub>), conjugative transfer genes, and replicon genes, before and after antibiotic treatment. The resulting <italic>p</italic>-values were adjusted using the Benjamini-Hochberg method to control the false discovery rate. Genes with an adjusted <italic>p</italic>-value&lt;0.05, identified by DESeq, were classified as differentially expressed.</p>
<disp-formula id="eq2">
<label>(1.2)</label>
<mml:math display="block" id="M2">
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>l</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
</mml:mstyle>
<mml:mn>2</mml:mn>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>F</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>l</mml:mi>
<mml:mi>d</mml:mi>
<mml:mi>C</mml:mi>
<mml:mi>h</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>g</mml:mi>
<mml:mi>e</mml:mi>
</mml:mstyle>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>=</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>l</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>g</mml:mi>
</mml:mstyle>
<mml:mn>2</mml:mn>
<mml:mfrac>
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>c</mml:mi>
</mml:mstyle>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>t</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>a</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>d</mml:mi>
</mml:mstyle>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>g</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>p</mml:mi>
</mml:mstyle>
</mml:mrow>
<mml:mrow>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>a</mml:mi>
<mml:mi>n</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>b</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>t</mml:mi>
<mml:mi>i</mml:mi>
<mml:mi>c</mml:mi>
</mml:mstyle>
<mml:mo>&#x2212;</mml:mo>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>f</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>e</mml:mi>
<mml:mi>e</mml:mi>
</mml:mstyle>
<mml:mtext>&#x2009;</mml:mtext>
<mml:mstyle mathvariant="bold" mathsize="normal">
<mml:mi>g</mml:mi>
<mml:mi>r</mml:mi>
<mml:mi>o</mml:mi>
<mml:mi>u</mml:mi>
<mml:mi>p</mml:mi>
</mml:mstyle>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
</disp-formula>
</sec>
<sec id="s2_8">
<title>Quantitative real-time polymerase chain reaction</title>
<p>All primers and probes for <italic>bla</italic>
<sub>KPC-2</sub> gene, <italic>bla</italic>
<sub>VIM-2</sub> gene, and <italic>repA</italic> genes (Inc<sub>pRBL16</sub> and IncP6) were designed using Primer 5.0 software, based on the sequences from strain 18102011 carrying plasmid 1 (CP116229) and plasmid 2 (CP116230) (The primer sequences are listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S4</bold>
</xref>). DNA contamination was removed from RNA samples using the 4x gDNA wiper rMix (reaction conditions: 42&#xb0;C for 2 min). cDNA was then synthesized using the used 5x HiScripII qRT SuperMIx II. The reverse transcription program included incubation at 50 &#xb0;C for 15 min, followed by incubation at 85 &#xb0;C for 5 s. Quantitative real-time polymerase (qPCR) analysis specifically targeted four key genetic elements. These included the <italic>bla</italic>
<sub>KPC-2</sub> gene and <italic>bla</italic>
<sub>VIM-2</sub> gene responsible for encoding KPC-2 and VIM-2 carbapenemases respectively. The analysis also targeted the Inc<sub>pRBL16</sub> <italic>repA</italic> and IncP6 <italic>repA</italic> genes, which encode essential replication initiation proteins for plasmid 1 and plasmid 2 (The qPCR conditions were listed in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S5</bold>
</xref>). The experiment was conducted with three technical replicates using three-fold serial dilutions of cDNA. The entire experimental procedure was repeated three times.</p>
</sec>
<sec id="s2_9">
<title>Nucleotide sequence accession numbers</title>
<p>The complete sequences of strain 18102011, plasmid pP2011-1, and plasmid pP2011&#x2013;2 have been submitted to GenBank under the accession numbers CP116228, CP116229, and CP116230, respectively. The transcriptome data of strain 18102011 and its plasmids before and after the addition of imipenem have been uploaded to the China National Center for Bioinformatics (CNCB) (<ext-link ext-link-type="uri" xlink:href="http://ngdc.cncb.ac.cn/gsub/">http://ngdc.cncb.ac.cn/gsub/</ext-link>) under accession number CRA023298.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results and discussion</title>
<sec id="s3_1">
<title>Identification and antimicrobial resistance profile of strain 18102011</title>
<p>After strain 18102011 was cultured overnight at 37&#xb0;C on Brain Heart Infusion (BHI) agar containing an imipenem concentration of 4 &#x3bc;g/mL, distinct colonies with smooth and regular edges, measuring approximately 0.5 mm in diameter, were observed. These colonies exhibited non-fusion growth, and pyocyanin production, and were devoid of metallic sheens. Subsequently, strain 18102011 was identified as <italic>P. aeruginosa</italic> using the BD Phoenix-100 automated identification system and sequencing of the <italic>oprL</italic> gene, a marker specific to this species. Following this identification, a comprehensive analysis of its drug resistance spectrum was conducted, revealing resistance to all evaluated antibiotics (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables S1</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>S2</bold>
</xref>).</p>
</sec>
<sec id="s3_2">
<title>Genomic characterization of the <italic>P. aeruginosa</italic> strain 18102011</title>
<p>To characterize the genome of the bacterium thoroughly, we employed Single Molecule Real-Time (SMRT) sequencing. The genome sequencing data revealed a 6.6 Mb chromosome in strain 18102011 (GenBank ID: CP116228), exhibiting a GC content of 66.2%. Additionally, the presence of two plasmids was detected in this bacterium. This strain&#x2019;s genome revealed an ANI value of &#x2265;95% with the reference strain <italic>P. aeruginosa</italic> PAO1 (GenBank ID: NC_002516.2), verifying the species information for this bacterium again.</p>
<p>The molecular genetic characteristics of the bacterium were analyzed to determine whether it was a member of a potential epidemic clone group. The isolate belonged to the multi-locus sequence type ST2374 and serotype O4 based on MLST and PAst identification, respectively. As of March 2024, the pbMLST database contained two total strains of ST2374 <italic>P. aeruginosa</italic>, including strain SX69 from a sputum origin in China and strain 127Gr isolated from soft tissue in Belarus in 2016. More than twenty serotypes of <italic>P. aeruginosa</italic> were known, of which serotype O4 was not known as a multidrug-resistant serotype (<xref ref-type="bibr" rid="B32">Nasrin et&#xa0;al., 2022</xref>). However, serotype switching from O4 to the multidrug-resistant serotype O12 had been observed under specific conditions (<xref ref-type="bibr" rid="B43">Thrane et&#xa0;al., 2015</xref>).</p>
<p>Three virulence genes were detected on the chromosome of strain 18102011: the phospholipase C (PLC) gene (<italic>plcH</italic>) and exotoxin genes (<italic>exoS</italic> and <italic>exoT</italic>). PLC was a thermolabile hemolysin that degrades phospholipid surfactants and reduces surface tension, thus preventing alveoli from collapsing completely when air leaves them during breathing (<xref ref-type="bibr" rid="B25">Khan et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B45">Wang et&#xa0;al., 2021</xref>). The ExoS and ExoT proteins could be secreted via the type III secretion system (T3SS) and could disrupt the cytoskeleton, induce host cell rounding, disrupt intercellular tight junctions, prevent wound healing, and inhibit bacterial internalization into epithelial cells and macrophages (<xref ref-type="bibr" rid="B38">Rao et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B22">Jouault et&#xa0;al., 2022</xref>). Consistent with previous reports, the isolate harboring <italic>exoS</italic>-like sequences did not contain <italic>exoU</italic>-like sequences (<xref ref-type="bibr" rid="B15">Feltman et&#xa0;al., 2001</xref>). In this study, in addition to the <italic>exoU</italic> gene encoding ExoU (a T3SS effector), the <italic>exoA</italic> gene encoding Exotoxin A (ExoA), which was also a strong pathogenic virulence factor such as ExoU, was not identified (<xref ref-type="bibr" rid="B21">J&#xf8;rgensen et&#xa0;al., 2005</xref>; <xref ref-type="bibr" rid="B16">Foulkes et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B30">Morgan et&#xa0;al., 2021</xref>). Additionally, the <italic>exoY</italic> gene encoding ExoY (another T3SS effector) was also not detected in this study. It might exhibit greater cytotoxicity to epithelial cells than strains secreting active ExoY, as ExoY had been found to possibly play a protective role at certain stages of bacterial infection, either to facilitate host colonization or to establish and/or maintain chronic infection in the host (<xref ref-type="bibr" rid="B40">Silistre et&#xa0;al., 2021</xref>). Thus, this strain might cause cellular damage in immunocompromised patients, but it didn&#x2019;t cause acute toxicity.</p>
<p>According to the Resfinder database, CARD database, and PCR results, the bacteria carried the acquired genes <italic>bla</italic>
<sub>VIM-2</sub> and <italic>bla</italic>
<sub>KPC-2</sub> simultaneously. Furthermore, through the Resfinder platform, other acquired resistance genes were identified in strain 18102011, including aminoglycoside resistance genes (<italic>aph(3&#x2019;)-IIb</italic>, <italic>aac(6&#x2019;)-Ib-cr</italic>, <italic>ant(2&#x2019;&#x2019;)-Ia</italic>), &#x3b2;-lactam resistance genes (<italic>bla</italic>
<sub>OXA-396</sub>, <italic>bla</italic>
<sub>PAO</sub>, <italic>bla</italic>
<sub>PER-1</sub>), a sulfonamide resistance gene (<italic>sul1</italic>), a chloramphenicol resistance gene (<italic>catB7</italic>), a quinolone resistance gene (<italic>qnrVC6</italic>), and a fosfomycin resistance gene (<italic>fosA</italic>). These resistance genes were inserted into chromosomes and plasmids by mobile elements. Plasmid-mediated drug resistance genes could lead to their rapid spread among bacteria. Pan-resistance <italic>P. aeruginosa</italic> co-carrying <italic>bla</italic>
<sub>VIM-2</sub> and <italic>bla</italic>
<sub>KPC-2</sub> genes was first reported in Colombia and had subsequently spread in this country, harboring many resistance genes (<xref ref-type="bibr" rid="B11">Correa et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B37">Rada et&#xa0;al., 2021</xref>), which was not common in China.</p>
</sec>
<sec id="s3_3">
<title>Overview of plasmid pP2011&#x2013;1 carrying <italic>bla</italic>
<sub>VIM-2</sub>
</title>
<p>The bacteria carried two plasmids, which were named pP2011&#x2013;1 and pP2011-2, in this study. The mega-plasmid pP2011-1 (GenBank ID: CP116229) carrying <italic>bla</italic>
<sub>VIM-2</sub> was 474 kb and exhibited a GC content of 56.9%. The plasmid harbored a <italic>repA</italic> (replication initiation) gene sharing &#x2265;96% nucleotide identity to <italic>repA</italic>
<sub>IncpRBL16</sub>. The Inc<sub>pRBL16</sub> plasmid was first reported in the mega-plasmid p12969-DIM (GenBank ID: KU130294) of strain <italic>P. aeruginosa</italic> 12969 (<xref ref-type="bibr" rid="B42">Sun et&#xa0;al., 2016</xref>). As of March 2024, there were many genomes containing <italic>repA</italic>
<sub>IncpRBL16-like</sub> sequences in the GenBank database, all of which belonged to <italic>Pseudomonas</italic> spp. However, the pP2011&#x2013;1 plasmid had a low genetic identified with the previously reported Inc<sub>pRBL16</sub> family plasmid (<xref ref-type="bibr" rid="B20">Jiang et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B14">Dong et&#xa0;al., 2022</xref>), and there were large structural variations. The Inc<sub>pRBL16</sub> family plasmids carried by bacteria may have co-evolved with their chromosomes to maintain their presence in the host bacteria.</p>
<p>As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, the backbone of plasmid pP2011&#x2013;1 contained genes for partitioning (<italic>parB2-parAB</italic>), conjugal transfer (<italic>cpl</italic> and <italic>tivF</italic>), chemotaxis (<italic>che</italic>), pilus assembly (<italic>pil</italic>), and tellurium resistance (<italic>ter</italic>), in addition to <italic>repA</italic>
<sub>IncpRBL16</sub> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). The plasmid also contained 3 novel recombination sites in addition to the common recombination site 2 for Inc<sub>pRBL16</sub> family plasmids (<xref ref-type="bibr" rid="B20">Jiang et&#xa0;al., 2020</xref>). IS<italic>Pa75</italic> (IS<italic>66</italic> family) and <italic>fosA</italic> formed the accessory module 1 region that was inserted between two hypothetical proteins of the tellurium resistance region. In addition, <italic>dnaK</italic> and <italic>yaeT</italic>, along with several phage integrase genes and stress protein genes, form the accessory module 2 region that was inserted into the region of the catalytic subunit of Pol V (UmuC), which was a major recombination site of Inc<sub>pRBL16</sub> family plasmids. During conjugation, plasmids were transferred as single-stranded DNA, which in turn activates the bacterial SOS stress response. The SOS response coordinated the expression of dozens of bacterial genes involved in DNA repair and cell cycle control, and it was known to fuel bacterial evolvability through an increase in recombination and mutagenesis (<xref ref-type="bibr" rid="B39">Rodr&#xed;guez-Beltr&#xe1;n et&#xa0;al., 2021</xref>). The accessory module 3 region comprised heavy-metal efflux protein genes (<italic>merE</italic>, <italic>merD</italic>, <italic>merA</italic>, <italic>merP</italic>, <italic>merT</italic>, and <italic>merR</italic>), Tn<italic>6001</italic> (Tn<italic>3</italic> family), two copies of IS<italic>CR1</italic> (IS<italic>91</italic> family), <italic>bla</italic>
<sub>PER-1</sub>, and <italic>qnrVC6</italic>, and a novel class 1 integron In2057 carrying <italic>ant(2&#x2019;&#x2019;)-IIa</italic>, <italic>bla</italic>
<sub>VIM-2</sub> and <italic>aac(6&#x2019;)-Ib-cr</italic>, which was inserted between the hypothetical protein genes that were 708 bp and 1,257 bp in length. Finally, the accessory module 4 region included IS<italic>Pa141</italic> (IS<italic>30</italic> family), IS<italic>Pa61</italic> (IS<italic>L3</italic> family), IS<italic>Pst3</italic> (IS<italic>21</italic> family), IS<italic>Pa60</italic> (IS<italic>As1</italic> family), Tn<italic>4662a</italic> (Tn<italic>3</italic> family), and Tn<italic>5046.1</italic> (Tn<italic>3</italic> family), which were inserted between the hypothetical protein and phage protein genes.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Annotation of the plasmid pP2011-1. The circles represented (from outside to inside) the following: (1) Genome functional annotation. The backbone region was black, the plasmid replicon was brown, the PRTRC system was red, the <italic>che</italic> region was dark green, the parB2-parAB region was yellow, the <italic>pil</italic> region was lighter green, and the <italic>ter</italic> region was bright green. The IS<italic>Pa75</italic> and <italic>fosA</italic> genes form the accessory module 1 region (dark cyan), whereas the <italic>dnaK</italic> and <italic>yaeT</italic> genes, along with several phage integrase genes and stress protein genes, form the accessory module 2 region (purple), which was inserted into the UmuC region (purple). The accessory module 3 region (pink) comprises Tn<italic>6011</italic> (pink) and In2057 (orange). The accessory module 4 region (green-yellow) comprises IS<italic>pa141</italic> (olive), IS<italic>pa61</italic> (dark blue), IS<italic>pst3</italic> (turquoise), IS<italic>Pa60</italic> (honeydew), Tn<italic>4662a</italic> (green-yellow) and Tn<italic>5046.1</italic> (alice blue); (2) GC skew calculated as [(G-C)/(G+C)]; and (3) GC content.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1617614-g001.tif">
<alt-text content-type="machine-generated">Circular diagram of plasmid pP2011_1, showing its 474.03 Kb length. The outer ring displays various colored segments representing different functional regions, including maintenance, replication, and accessory modules. Inner rings illustrate GC content and skew. Color-coded legend identifies specific sequence features and elements.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_4">
<title>Overview of plasmid pP2011&#x2013;2 carrying <italic>bla</italic>
<sub>KPC-2</sub>
</title>
<p>As shown in <xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>, the pP2011&#x2013;2 plasmid (GenBank ID: CP116230) carrying <italic>bla</italic>
<sub>KPC-2</sub> was 40 kb in length and exhibited a GC content of 58.1%. The plasmid harbored a <italic>repA</italic> gene sharing &#x2265;96% nucleotide identity to <italic>repA</italic>
<sub>Incp6</sub>. The IncP6 plasmid was first identified in pRms149 (GenBank ID: GCA_019400855.1) of the <italic>P. aeruginosa</italic> JX05 strain in 2005 (<xref ref-type="bibr" rid="B17">Haines et&#xa0;al., 2005</xref>). According to the GenBank database, this replicon sequence could be found in Enterobacteriaceae, <italic>P. aeruginosa</italic>, and <italic>Aeromonas</italic> strains. The backbone of the <italic>repA</italic>
<sub>Incp6</sub> family plasmid included <italic>repA</italic>
<sub>Incp6</sub>, genes for partitioning (<italic>parABC</italic>), and a mobilization region (<italic>mobABCDE</italic>), in addition to two accessory modules in this study. The accessory module 1 region comprised Tn<italic>5563a</italic> (Tn<italic>3</italic> family) and IS<italic>Pa19</italic>, whereas accessory module 2 includes IS<italic>Ec33</italic>-Tn<italic>3</italic>-IS<italic>Apu2</italic>-IS<italic>Apu2</italic>-<italic>orf7</italic>-IS<italic>Kpn27</italic>-<italic>bla</italic>
<sub>KPC-2</sub>-&#x394;IS<italic>Kpn6-korC-orf6-klcA-</italic>&#x394;<italic>repB</italic>. Typical transposons Tn<italic>4401</italic> and Tn<italic>1722</italic>, both members of Tn<italic>3</italic> family, have been demonstrated to mobilize the <italic>bla</italic>
<sub>KPC-2</sub> at high transposition frequencies (<xref ref-type="bibr" rid="B41">Song et&#xa0;al., 2024</xref>). KPC-1/KPC-2 was first identified in <italic>Klebsiella pneumoniae</italic> in 2001 (<xref ref-type="bibr" rid="B46">Yigit et&#xa0;al., 2001</xref>). While KPC carried by Enterobacteriaceae, it has also been detected in non-Enterobacteriaceae due to horizontal gene transfer, such as <italic>P. aeruginosa</italic>. Tn<italic>4401</italic> is a removable element that commonly carries the <italic>bla</italic>
<sub>KPC-2</sub> gene in Europe, Brazil, and the United States. In Asia, <italic>bla</italic>
<sub>KPC-2</sub> is mainly located on different variants of Tn<italic>1722</italic>-like transposons (<xref ref-type="bibr" rid="B41">Song et&#xa0;al., 2024</xref>). Zhang DF et&#xa0;al. found that there were three divergent forms of <italic>bla</italic>
<sub>KPC-2</sub> transposon unit in <italic>K. pneumoniae</italic>, including Tn<italic>1721</italic>-<italic>bla</italic>
<sub>KPC-2</sub> transposon, IS<italic>26</italic>-Tn<italic>1721</italic>-<italic>bla</italic>
<sub>KPC-2</sub> transposon and IS<italic>26</italic>-<italic>bla</italic>
<sub>KPC-2</sub> transposon (<xref ref-type="bibr" rid="B48">Zhang et&#xa0;al., 2022</xref>). The IncP6 plasmid (p10265-KPC) was first characterized in 2016, different from the Tn<italic>1722/</italic>Tn<italic>1721</italic>-like unit transposons (pKP048 from <italic>K. pneumoniae</italic>), the IS<italic>Apu1</italic>-<italic>orf7</italic>-IS<italic>Apu2</italic> structure truncates the Tn<italic>3</italic> transposase and inserts a truncated <italic>bla</italic>
<sub>TEM-1</sub> gene downstream of IS<italic>Kpn27</italic> (<xref ref-type="bibr" rid="B12">Dai et&#xa0;al., 2016</xref>). In this study, the distinction lines in the fact that p10265-KPC has a truncated <italic>bla</italic>
<sub>TEM-1</sub> gene inserted between IS<italic>Kpn27</italic> and the <italic>bla</italic>
<sub>KPC-2</sub> gene (<xref ref-type="bibr" rid="B12">Dai et&#xa0;al., 2016</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Annotation of plasmid pP2011-2. The circles represented (from outside to inside) the following: (1) Genome functional annotation. The backbone region was black, in which the plasmid replicon was green. Tn<italic>5563a</italic> (pink) and IS<italic>Pa19</italic> (sea-green) comprise the accessory module 1 region (pink), whereas the module 2 region (orange) comprises IS<italic>Kpn6</italic> (red), <italic>bla</italic>
<sub>KPC-2</sub> (magenta), IS<italic>Kpn27</italic> (yellow), Tn<italic>3</italic> (orange), IS<italic>Apu2</italic> (blue), and IS<italic>Ec33</italic> (purple); (2) the GC skew was calculated as [(G-C)/(G+C)]; and (3) the GC content.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1617614-g002.tif">
<alt-text content-type="machine-generated">Circular diagram of plasmid pP2011_2 with a total length of 39.87 kilobases. It features two accessory module regions in pink and orange. The backbone, maintenance, plasmid replication, and various accessory modules are color-coded. The accessory modules include ISKpn6, Tn3, Tn5563a, IS4321R, ISAPU2, ISKpn27, and blaKPC-2.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_5">
<title>Conjugative transfer and resistance phenotype dissemination of <italic>bla</italic>
<sub>VIM-2</sub> and <italic>bla</italic>
<sub>KPC-2</sub>-encoding plasmids</title>
<p>To evaluate the transferability of plasmids harboring <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub>, conjugation assays were performed by co-culturing the strain 18102011 with <italic>E. coli</italic> EC600. Conjugants grown on dilution gradients of 10<sup>-1</sup>, 10<sup>-2</sup>, and 10<sup>-3</sup>. And recipient bacteria can grow on all dilution gradients from 10&#x2013;<sup>1</sup> to 10&#x2013;<sup>9</sup> on a medium containing only rifampicin. The conjugation transfer efficiency was calculated to be 10&#x2013;<sup>6</sup> using the <xref ref-type="disp-formula" rid="eq1">
<bold>Equation (1.1)</bold>
</xref>. Because the IncP6 plasmid lacked a conjugation-transfer region and only had a mobile region, the plasmid could only carry out horizontal transfer under the synergistic action of the conjugation plasmid Inc<sub>pRBL16</sub> (<xref ref-type="bibr" rid="B9">Coluzzi et&#xa0;al., 2022</xref>). In this study, all suspected transconjugants were picked from the culture medium at 10<sup>3</sup> dilution gradients, with number of 19, 15, and 21 respectively (corresponding to three parallel replicates). A single carbapenem-resistant gene, namely <italic>bla</italic>
<sub>KPC-2</sub> or <italic>bla</italic>
<sub>VIM-2</sub>, was not found by conjugation assays. Although the MICs of transconjugant D2011 for many antibiotics tested decreased significantly, indicating susceptibility, it was still resistant to imipenem and meropenem (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Tables S1</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>S2</bold>
</xref>). The MICs of strain 18102011 and its transconjugant D2011 against imipenem were determined by broth method, both of which were 4,096 &#x3bc;g/mL. Therefore, the main resistance mechanism of strain 18102011 to carbapenem antibiotics was plasmid-mediated <italic>bla</italic>
<sub>VIM-2</sub> and <italic>bla</italic>
<sub>KPC-2</sub> genes, resulting in a stable carbapenem-resistant transmission phenotype.</p>
</sec>
<sec id="s3_6">
<title>Plasmid stability and fitness cost analysis of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub>-co-harboring strain 18102022</title>
<p>The impact of the acquisition of both plasmids carrying <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> on the biological fitness cost was evaluated. Notably, the OD<sub>600</sub> of recipient strain <italic>E. coli</italic> EC600 was significantly lower than that of the transconjugant D2011 (carrying <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub>) in 12h. Taken together, these microbiological characteristics indicated that strain 18102011 could carry both the <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes without compromising their fitness and maintaining them stably over time (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3a</bold>
</xref>). Furthermore, during serial passage in the laboratory for 10 days to evaluate the stability of plasmids carrying <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> from strain 1810211. Interestingly, both the <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> plasmids were present in 50 colonies (100%, 50/50) on the 5<sup>th</sup> and 10<sup>th</sup> day, respectively, indicating high stability (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3b</bold>
</xref>, PCR identification of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes of the strain D2011 on 5<sup>th</sup> and 10<sup>th</sup> day were shown in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>). This increased our concern about <italic>bla</italic>
<sub>KPC-2</sub>-<italic>bla</italic>
<sub>VIM-2</sub>-CRPA, as it posed not only significant challenges in treatment but also a remarkable ability to stably maintain these plasmids without apparent fitness costs, making it difficult to retrogress.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Growth curves of strain D2011 and stability of the <italic>bla</italic>
<sub>KPC-2</sub> or <italic>bla</italic>
<sub>VIM-2</sub> gene. <bold>(a)</bold> Growth curve of strain D2011 carrying the <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes and <italic>E</italic>. <italic>coli</italic> EC600. <bold>(b)</bold> Stability of the <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes during the 10-day serial passage. <italic>p</italic>&lt; 0.05 *(significant), <italic>p</italic>&lt; 0.01 ** (highly significant).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1617614-g003.tif">
<alt-text content-type="machine-generated">Two graphs labeled &#x201c;a&#x201d; and &#x201c;b.&#x201d; Graph (a) shows OD600 growth over time in hours for D2011 (blue circles) and EC600 (purple squares). D2011 increases significantly, while EC600 remains stable, marked by an asterisk. Graph (b) shows a gene expression percentage over time in days for 18102011 (cyan line), remaining constant at one hundred percent.</alt-text>
</graphic>
</fig>
</sec>
<sec id="s3_7">
<title>Transcriptional regulation of <italic>bla</italic>
<sub>VIM-2</sub> and <italic>bla</italic>
<sub>KPC-2</sub> under carbapenem pressure</title>
<p>The integron In2057-<italic>bla</italic>
<sub>VIM-2</sub> sequence was uploaded into the BPROM database, revealing only one promoter with the -10/-35 region (AGCTTACCA/TGTCCA) located within In2057&#x2019;s integrase. This promoter sequence matched the PcW<sub>TGN-10</sub> promoter sequence identified in the research by Nesvera J et&#xa0;al., driving the expression of the downstream gene cassette (<xref ref-type="bibr" rid="B33">Nesvera et&#xa0;al., 1998</xref>). It had been reported that the TGN-10 motif increased the PcW promoter strength efficiency 15-fold (<xref ref-type="bibr" rid="B23">Jov&#xe9; et&#xa0;al., 2010</xref>). Therefore, this promoter might have increased the expression of a series of downstream gene cassettes in this study, including <italic>bla</italic>
<sub>VIM-2</sub>. This might be one of the reasons for the high resistance of bacteria to carbapenem.</p>
<p>The IS<italic>Kpn27</italic>-<italic>bla</italic>
<sub>KPC-2</sub> sequence was uploaded into the BPROM database. Only one promoter with the -10/-35 region (ATGTAA/GGATTA) was identified between the IS<italic>Kpn27</italic> and <italic>bla</italic>
<sub>KPC-2</sub> genes. This promoter sequence was consistent with the P1 promoter sequence commonly found in IS<italic>Kpn7</italic>-<italic>bla</italic>
<sub>KPC-2</sub>, which drove the expression of the downstream <italic>bla</italic>
<sub>KPC-2</sub> gene (<xref ref-type="bibr" rid="B18">Huang et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B19">Huang et&#xa0;al., 2020</xref>).</p>
<p>Through transcriptome analysis of the expression of the <italic>bla</italic>
<sub>VIM-2</sub> gene carried by plasmid pP2011&#x2013;1 and the <italic>bla</italic>
<sub>KPC-2</sub> gene carried by plasmid pP2011-2, it was found that both genes were up-regulated when imipenem was added to the culture medium (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>, the data for <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S6</bold>
</xref>). However, after the addition of imipenem, the expression level of <italic>bla</italic>
<sub>VIM-2</sub> significantly increased, which might be related to the regulatory effect of its upstream strong promoter (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4</bold>
</xref>, <xref ref-type="fig" rid="f5">
<bold>5</bold>
</xref>, the data for <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref> can be found in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S7</bold>
</xref>). Additionally, under the influence of imipenem, the expression levels of some other genes on the plasmid also changed. For example, the expression levels of plasmid conjugative transfer gene (<italic>tra</italic>), the mobilization genes (<italic>mob</italic>, excluding <italic>mobA</italic>), and the <italic>repA</italic> gene on the IncpRBL16 plasmid all showed increase, although this increase was not significant (<xref ref-type="fig" rid="f4">
<bold>Figures&#xa0;4</bold>
</xref>, <xref ref-type="fig" rid="f5">
<bold>5</bold>
</xref>). The low levels of read counts (FPKM) for the replicon genes <italic>repA</italic> (located on the Inc<sub>pRBL16</sub> plasmids) and the conjugative transfer gene (<italic>traD</italic>) indicated their low expression levels (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S6</bold>
</xref>). Since the <italic>repA</italic> gene is a key factor for initiating plasmid replication, its low expression leads to a reduction in plasmid copy number. This could be a strategy employed by the Inc<sub>pRBL16</sub> plasmid to decrease its fitness cost to the host bacterium by maintaining a lower copy number (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Read counts of the Inc<sub>pRBL16</sub> (<italic>repA</italic>), IncP6 (<italic>repA</italic>), <italic>bla</italic>
<sub>VIM-2</sub>, <italic>bla</italic>
<sub>KPC-2</sub>, conjugative transfer genes (<italic>tra</italic>), and mobile genetic genes (<italic>mob</italic>) in strain 18102011. The horizontal axis represents gene name, whereas the vertical axis represents change in read counts (FPKM) of genes after imipenem addition (expressed as log<sub>2</sub>FoldChange). <italic>p</italic>&lt;0.05 *(significant), <italic>p</italic>&lt;0.01 **(highly significant).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1617614-g004.tif">
<alt-text content-type="machine-generated">Bar graph displaying log2 fold change for various genes, including traD, mobA, and others. Values range from -0.862 to 0.801, with IncpRBL16 having the highest increase and IncP6 the steepest decrease. A legend indicates gene color coding.</alt-text>
</graphic>
</fig>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Results of qPCR identification of the Inc<sub>pRBL16</sub> (<italic>repA</italic>), IncP6 (<italic>repA</italic>), <italic>bla</italic>
<sub>VIM-2</sub>, and <italic>bla</italic>
<sub>KPC-2</sub> in strain 18102011. The horizontal axis represents group classifications (IncP6; Inc<sub>pRBL16</sub>; <italic>bla</italic>
<sub>KPC-2</sub>; <italic>bla</italic>
<sub>VIM-2</sub>), whereas the vertical axis represents amplification fold. <italic>p</italic>&lt;0.05 *(significant), <italic>p</italic>&lt;0.01 **(highly significant), <italic>p</italic>&gt;0.05 ns (not significant).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-15-1617614-g005.tif">
<alt-text content-type="machine-generated">Bar chart showing amplification fold for IncP6, IncpRBL16, blaKPC-2, and blaVIM-2. IncP6 and IncpRBL16 show no significant change (ns), while blaKPC-2 and blaVIM-2 show significant changes, indicated by asterisks. Amplification ranges from -2 to 4.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="conclusions">
<title>Conclusion</title>
<p>Currently, there were relatively few reports on pan-resistant <italic>P. aeruginosa</italic> co-carrying <italic>bla</italic>
<sub>VIM-2</sub> and <italic>bla</italic>
<sub>KPC-2</sub> genes in China, which were mostly concentrated in Columbia. The limited existing reports also lacked an analysis of the fitness costs associated with the plasmids carried by these bacteria. In this study, the presence of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> plasmids didn&#x2019;t cause fitness costs to the growth of the host bacteria. Since the IncP6 plasmid lacked a conjugation transfer region, its horizontal transfer required the assistance of Inc<sub>pRBL16</sub> conjugation plasmids for co-transfer into <italic>E. coli</italic> EC600. Through horizontal plasmid transfer, high-level resistance to imipenem was stably maintained within the bacterial population. However, there were differences in the composition of the cell membranes between <italic>P. aeruginosa</italic> and <italic>E. coli</italic>, causing the pan-drug resistant phenotype to not be shared between the donor and recipient bacteria through plasmid conjugation transfer. As the treatment of pan-drug resistant bacteria was extremely challenging, their epidemiological and molecular genetics across the world should be closely monitored.</p>
</sec>
</body>
<back>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>Publicly available datasets were analyzed in this study. This data can be found here: The complete sequences of strain 18102011, plasmid pP2011-1, and plasmid pP2011-2 have been submitted to GenBank under the accession numbers CP116228, CP116229, and CP116230, respectively. The transcriptome data of strain 18102011 and its plasmids before and after the addition of imipenem have been uploaded to the China National Center for Bioinformatics (CNCB) (<uri xlink:href="http://ngdc.cncb.ac.cn/gsub/">http://ngdc.cncb.ac.cn/gsub/</uri>) under accession number CRA023298.</p>
</sec>
<sec id="s6" sec-type="author-contributions">
<title>Author contributions</title>
<p>LZ: Conceptualization, Investigation, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing, Data curation, Validation, Visualization, Methodology. ZW: Writing &#x2013; original draft. GL: Writing &#x2013; original draft, Supervision. XZ: Supervision, Validation, Writing &#x2013; original draft. JJ: Writing &#x2013; original draft, Supervision, Validation. SS: Project administration, Writing &#x2013; original draft. YS: Writing &#x2013; original draft, Resources, Project administration, Funding acquisition. XJ: Writing &#x2013; original draft, Project administration. BJ: Project administration, Writing &#x2013; original draft. LWZ: Conceptualization, Resources, Funding acquisition, Methodology, Supervision, Writing &#x2013; review &amp; editing. XG: Methodology, Investigation, Data curation, Funding acquisition, Resources, Project administration, Conceptualization, Writing &#x2013; review &amp; editing.</p>
</sec>
<sec id="s7" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research and/or publication of this article. Funding for the study design, data collection, data generation, and publication costs was provided by Jilin Provincial Department of Finance (jcsz2023481-1) and the National Science and Natural Science Foundation of China (Grant agreement 31872486).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We are grateful to the members of the China-Japan Union Hospital, Jilin University.</p>
</ack>
<sec id="s8" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</p>
</sec>
<sec id="s9" sec-type="ai-statement">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2025.1617614/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2025.1617614/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.pdf" id="SF1" mimetype="application/pdf">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>PCR identification of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes of strain 18102011 on the 5<sup>th</sup> and 10<sup>th</sup> day. (a) PCR identification of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes of strain 18102011 on the 5<sup>th</sup> day; (b) PCR identification of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes of strain 18102011 on the 10<sup>th</sup> day; (c) PCR identification of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes of strain 18102011 on the 5<sup>th</sup> day (repeat); (d) PCR identification of <italic>bla</italic>
<sub>KPC-2</sub> and <italic>bla</italic>
<sub>VIM-2</sub> genes of strain 18102011 on the 10<sup>th</sup> day (repeat).</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Table1.xlsx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alcock</surname> <given-names>B. P.</given-names>
</name>
<name>
<surname>Huynh</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Chalil</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>K. W.</given-names>
</name>
<name>
<surname>Raphenya</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Wlodarski</surname> <given-names>M. A.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database</article-title>. <source>Nucleic Acids Res.</source> <volume>51</volume>, <fpage>D690</fpage>&#x2013;<lpage>d699</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkac920</pub-id>, PMID: <pub-id pub-id-type="pmid">36263822</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Allameh</surname> <given-names>S. F.</given-names>
</name>
<name>
<surname>Nemati</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Ghalehtaki</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Mohammadnejad</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Aghili</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Khajavirad</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Clinical characteristics and outcomes of 905 COVID-19 patients admitted to imam khomeini hospital complex in the capital city of tehran, Iran</article-title>. <source>Arch. Iran Med.</source> <volume>23</volume>, <fpage>766</fpage>&#x2013;<lpage>775</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.34172/aim.2020.102</pub-id>, PMID: <pub-id pub-id-type="pmid">33220695</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blanc</surname> <given-names>D. S.</given-names>
</name>
<name>
<surname>Petignat</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Janin</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Bille</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Francioli</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Frequency and molecular diversity of <italic>Pseudomonas aeruginosa</italic> upon admission and during hospitalization: a prospective epidemiologic study</article-title>. <source>Clin. Microbiol. Infect.</source> <volume>4</volume>, <fpage>242</fpage>&#x2013;<lpage>247</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1469-0691.1998.tb00051.x</pub-id>, PMID: <pub-id pub-id-type="pmid">11864338</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boratyn</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Camacho</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Cooper</surname> <given-names>P. S.</given-names>
</name>
<name>
<surname>Coulouris</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Fong</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>BLAST: a more efficient report with usability improvements</article-title>. <source>Nucleic Acids Res.</source> <volume>41</volume>, <fpage>W29</fpage>&#x2013;<lpage>W33</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkt282</pub-id>, PMID: <pub-id pub-id-type="pmid">23609542</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bortolaia</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kaas</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Ruppe</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Roberts</surname> <given-names>M. C.</given-names>
</name>
<name>
<surname>Schwarz</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Cattoir</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>ResFinder 4.0 for predictions of phenotypes from genotypes</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>75</volume>, <fpage>3491</fpage>&#x2013;<lpage>3500</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkaa345</pub-id>, PMID: <pub-id pub-id-type="pmid">32780112</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Botelho</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Grosso</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Peixe</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Antibiotic resistance in <italic>Pseudomonas aeruginosa</italic> - Mechanisms, epidemiology and evolution</article-title>. <source>Drug Resist. Updat</source> <volume>44</volume>, <fpage>100640</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.drup.2019.07.002</pub-id>, PMID: <pub-id pub-id-type="pmid">31492517</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brettin</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Disz</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Edwards</surname> <given-names>R. A.</given-names>
</name>
<name>
<surname>Gerdes</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Olsen</surname> <given-names>G. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>RASTtk: a modular and extensible implementation of the RAST algorithm for building custom annotation pipelines and annotating batches of genomes</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>8365</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep08365</pub-id>, PMID: <pub-id pub-id-type="pmid">25666585</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cassiano</surname> <given-names>M. H. A.</given-names>
</name>
<name>
<surname>Silva-Rocha</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Benchmarking bacterial promoter prediction tools: potentialities and limitations</article-title>. <source>mSystems</source> <volume>5</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mSystems.00439-20</pub-id>, PMID: <pub-id pub-id-type="pmid">32843538</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coluzzi</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Garcill&#xe1;n-Barcia</surname> <given-names>M. P.</given-names>
</name>
<name>
<surname>de la Cruz</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Rocha</surname> <given-names>E. P. C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Evolution of plasmid mobility: origin and fate of conjugative and nonconjugative plasmids</article-title>. <source>Mol. Biol. Evol.</source> <volume>39</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/molbev/msac115</pub-id>, PMID: <pub-id pub-id-type="pmid">35639760</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cornaglia</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Mazzariol</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lauretti</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Rossolini</surname> <given-names>G. M.</given-names>
</name>
<name>
<surname>Fontana</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Hospital outbreak of carbapenem-resistant <italic>Pseudomonas aeruginosa</italic> producing VIM-1, a novel transferable metallo-beta-lactamase</article-title>. <source>Clin. Infect. Dis.</source> <volume>31</volume>, <fpage>1119</fpage>&#x2013;<lpage>1125</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/317448</pub-id>, PMID: <pub-id pub-id-type="pmid">11073738</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correa</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Del Campo</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Perenguez</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Blanco</surname> <given-names>V. M.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Ba&#xf1;os</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Perez</surname> <given-names>F.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Dissemination of high-risk clones of extensively drug-resistant <italic>Pseudomonas aeruginosa</italic> in Colombia</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>59</volume>, <fpage>2421</fpage>&#x2013;<lpage>2425</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.03926-14</pub-id>, PMID: <pub-id pub-id-type="pmid">25605362</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dai</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Xiong</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>The IncP-6 Plasmid p10265-KPC from Pseudomonas aeruginosa Carries a Novel &#x394;IS<italic>Ec33</italic>-Associated <italic>bla</italic> <sub>KPC-2</sub> Gene Cluster</article-title>. <source>Front. Microbiol.</source> <volume>7</volume>, <elocation-id>310</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2016.00310</pub-id>, PMID: <pub-id pub-id-type="pmid">27014233</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Vos</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>A.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Pirnay</surname> <given-names>J. P.</given-names>
</name>
<name>
<surname>Struelens</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Vandenvelde</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Duinslaeger</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>1997</year>). <article-title>Direct detection and identification of <italic>Pseudomonas aeruginosa</italic> in clinical samples such as skin biopsy specimens and expectorations by multiplex PCR based on two outer membrane lipoprotein genes, oprI and oprL</article-title>. <source>J. Clin. Microbiol.</source> <volume>35</volume>, <fpage>1295</fpage>&#x2013;<lpage>1299</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/jcm.35.6.1295-1299.1997</pub-id>, PMID: <pub-id pub-id-type="pmid">9163432</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dong</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Emergence of an Extensive Drug Resistant <italic>Pseudomonas aeruginosa</italic> Strain of Chicken Origin Carrying bla(IMP-45), tet(X6), and tmexCD3-toprJ3 on an Inc(pRBL16) Plasmid</article-title>. <source>Microbiol. Spectr</source> <volume>10</volume>, <fpage>e0228322</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/spectrum.02283-22</pub-id>, PMID: <pub-id pub-id-type="pmid">36301093</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feltman</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Schulert</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hauser</surname> <given-names>A. R.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa</article-title>. <source>Microbiol. (Reading)</source> <volume>147</volume>, <fpage>2659</fpage>&#x2013;<lpage>2669</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1099/00221287-147-10-2659</pub-id>, PMID: <pub-id pub-id-type="pmid">11577145</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foulkes</surname> <given-names>D. M.</given-names>
</name>
<name>
<surname>McLean</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Haneef</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Fernig</surname> <given-names>D. G.</given-names>
</name>
<name>
<surname>Winstanley</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Berry</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>
<italic>Pseudomonas aeruginosa</italic> toxin exoU as a therapeutic target in the treatment of bacterial infections</article-title>. <source>Microorganisms</source> <volume>7</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms7120707</pub-id>, PMID: <pub-id pub-id-type="pmid">31888268</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haines</surname> <given-names>A. S.</given-names>
</name>
<name>
<surname>Jones</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Thomas</surname> <given-names>C. M.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>The IncP-6 plasmid Rms149 consists of a small mobilizable backbone with multiple large insertions</article-title>. <source>J. Bacteriol.</source> <volume>187</volume>, <fpage>4728</fpage>&#x2013;<lpage>4738</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.187.14.4728-4738.2005</pub-id>, PMID: <pub-id pub-id-type="pmid">15995187</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Comparative analysis of bla(KPC) expression in tn<italic>4401</italic> transposons and the tn<italic>3</italic>-tn<italic>4401</italic> chimera</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>63</volume>:<elocation-id>e02434-18</elocation-id>. doi: <pub-id pub-id-type="doi">10.1128/AAC.02434-18</pub-id>, PMID: <pub-id pub-id-type="pmid">30833426</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ding</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Xv</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Genetic factors associated with enhanced bla(KPC) expression in tn<italic>3</italic>/tn<italic>4401</italic> chimeras</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>64</volume>. :<elocation-id>e01836-19</elocation-id>. doi: <pub-id pub-id-type="doi">10.1128/AAC.01836-19</pub-id>, PMID: <pub-id pub-id-type="pmid">31844015</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Yuan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Plasmids of novel incompatibility group IncpRBL16 from <italic>Pseudomonas</italic> species</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>75</volume>, <fpage>2093</fpage>&#x2013;<lpage>2100</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkaa143</pub-id>, PMID: <pub-id pub-id-type="pmid">32395746</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>J&#xf8;rgensen</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Merrill</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Yates</surname> <given-names>S. P.</given-names>
</name>
<name>
<surname>Marquez</surname> <given-names>V. E.</given-names>
</name>
<name>
<surname>Schwan</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Boesen</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2005</year>). <article-title>Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry</article-title>. <source>Nature</source> <volume>436</volume>, <fpage>979</fpage>&#x2013;<lpage>984</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature03871</pub-id>, PMID: <pub-id pub-id-type="pmid">16107839</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jouault</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Saliba</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Touqui</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Modulation of the immune response by the <italic>Pseudomonas aeruginosa</italic> type-III secretion system</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>, <elocation-id>1064010</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.1064010</pub-id>, PMID: <pub-id pub-id-type="pmid">36519135</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jov&#xe9;</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Da Re</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Denis</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Mazel</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Ploy</surname> <given-names>M. C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Inverse correlation between promoter strength and excision activity in class 1 integrons</article-title>. <source>PloS Genet.</source> <volume>6</volume>, <fpage>e1000793</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pgen.1000793</pub-id>, PMID: <pub-id pub-id-type="pmid">20066027</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kang</surname> <given-names>C. I.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H. B.</given-names>
</name>
<name>
<surname>Park</surname> <given-names>S. W.</given-names>
</name>
<name>
<surname>Choe</surname> <given-names>Y. J.</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>M. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2003</year>). <article-title>Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome</article-title>. <source>Clin. Infect. Dis.</source> <volume>37</volume>, <fpage>745</fpage>&#x2013;<lpage>751</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1086/377200</pub-id>, PMID: <pub-id pub-id-type="pmid">12955633</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Willcox</surname> <given-names>M. D. P.</given-names>
</name>
<name>
<surname>Rice</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Stapleton</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Development of antibiotic resistance in the ocular <italic>Pseudomonas aeruginosa</italic> clone ST308 over twenty years</article-title>. <source>Exp. Eye Res.</source> <volume>205</volume>, <fpage>108504</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.exer.2021.108504</pub-id>, PMID: <pub-id pub-id-type="pmid">33610601</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Gu</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T. Y.</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Peng</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>
<italic>Pseudomonas aeruginosa</italic>: A typical biofilm forming pathogen and an emerging but underestimated pathogen in food processing</article-title>. <source>Front. Microbiol.</source> <volume>13</volume>, <elocation-id>1114199</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2022.1114199</pub-id>, PMID: <pub-id pub-id-type="pmid">36762094</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Bi</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>ICEberg 2.0: an updated database of bacterial integrative and conjugative elements</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume>, <fpage>D660</fpage>&#x2013;<lpage>d665</lpage>. doi: <pub-id pub-id-type="doi">10.1093/nar/gky1123</pub-id>, PMID: <pub-id pub-id-type="pmid">30407568</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Zheng</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>VFDB 2022: a general classification scheme for bacterial virulence factors</article-title>. <source>Nucleic Acids Res.</source> <volume>50</volume>, <fpage>D912</fpage>&#x2013;<lpage>d917</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkab1107</pub-id>, PMID: <pub-id pub-id-type="pmid">34850947</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammadnejad</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Seifi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Ghanei Gheshlagh</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Aliramezani</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Fattah Ghazi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Salehi</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Determine phenotypical patterns of resistance to antibiotics in COVID-19 patients with associated bacterial infection: largest medical center in Iran</article-title>. <source>Iran J. Microbiol.</source> <volume>15</volume>, <fpage>336</fpage>&#x2013;<lpage>342</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.18502/ijm.v15i3.12893</pub-id>, PMID: <pub-id pub-id-type="pmid">37448685</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname> <given-names>R. N.</given-names>
</name>
<name>
<surname>Saleh</surname> <given-names>S. E.</given-names>
</name>
<name>
<surname>Aboshanab</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Farrag</surname> <given-names>H. A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>ADP-ribosyl transferase activity and gamma radiation cytotoxicity of <italic>Pseudomonas aeruginosa</italic> exotoxin A</article-title>. <source>AMB Express</source> <volume>11</volume>, <fpage>173</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13568-021-01332-3</pub-id>, PMID: <pub-id pub-id-type="pmid">34936047</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moura</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Pereira</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Leit&#xe3;o</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Henriques</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Correia</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>INTEGRALL: a database and search engine for integrons, integrases and gene cassettes</article-title>. <source>Bioinformatics</source> <volume>25</volume>, <fpage>1096</fpage>&#x2013;<lpage>1098</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/bioinformatics/btp105</pub-id>, PMID: <pub-id pub-id-type="pmid">19228805</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nasrin</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Hegerle</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Sen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Nkeze</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Sen</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Permala-Booth</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Distribution of serotypes and antibiotic resistance of invasive <italic>Pseudomonas aeruginosa</italic> in a multi-country collection</article-title>. <source>BMC Microbiol.</source> <volume>22</volume>, <fpage>13</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-021-02427-4</pub-id>, PMID: <pub-id pub-id-type="pmid">34991476</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nesvera</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Hochmannov&#xe1;</surname> <given-names>J.</given-names>
</name>
<name>
<surname>P&#xe1;tek</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>An integron of class 1 is present on the plasmid pCG4 from gram-positive bacterium Corynebacterium glutamicum</article-title>. <source>FEMS Microbiol. Lett.</source> <volume>169</volume>, <fpage>391</fpage>&#x2013;<lpage>395</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1574-6968.1998.tb13345.x</pub-id>, PMID: <pub-id pub-id-type="pmid">9868786</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Raudonis</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Glick</surname> <given-names>B. R.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>T. J.</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Z.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Antibiotic resistance in <italic>Pseudomonas aeruginosa</italic>: mechanisms and alternative therapeutic strategies</article-title>. <source>Biotechnol. Adv.</source> <volume>37</volume>, <fpage>177</fpage>&#x2013;<lpage>192</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.013</pub-id>, PMID: <pub-id pub-id-type="pmid">30500353</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Partridge</surname> <given-names>S. R.</given-names>
</name>
<name>
<surname>Kwong</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Firth</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Jensen</surname> <given-names>S. O.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mobile genetic elements associated with antimicrobial resistance</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>31</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/CMR.00088-17</pub-id>, PMID: <pub-id pub-id-type="pmid">30068738</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poirel</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Walsh</surname> <given-names>T. R.</given-names>
</name>
<name>
<surname>Cuvillier</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Nordmann</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Multiplex PCR for detection of acquired carbapenemase genes</article-title>. <source>Diagn. Microbiol. Infect. Dis.</source> <volume>70</volume>, <fpage>119</fpage>&#x2013;<lpage>123</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2010.12.002</pub-id>, PMID: <pub-id pub-id-type="pmid">21398074</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rada</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>de la Cadena</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Agudelo</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Pallares</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Restrepo</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Correa</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Genetic Diversity of Multidrug-Resistant <italic>Pseudomonas aeruginosa</italic> Isolates Carrying bla (VIM-2) and bla (KPC-2) Genes That Spread on Different Genetic Environment in Colombia</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>, <elocation-id>663020</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.663020</pub-id>, PMID: <pub-id pub-id-type="pmid">34512563</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rao</surname> <given-names>L.</given-names>
</name>
<name>
<surname>de la Rosa</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Sha</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Bhattacharya</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Holtzman</surname> <given-names>M. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Pseudomonas aeruginosa survives in epithelia by ExoS-mediated inhibition of autophagy and mTOR</article-title>. <source>EMBO Rep.</source> <volume>22</volume>, <fpage>e50613</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.15252/embr.202050613</pub-id>, PMID: <pub-id pub-id-type="pmid">33345425</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Beltr&#xe1;n</surname> <given-names>J.</given-names>
</name>
<name>
<surname>DelaFuente</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Le&#xf3;n-Sampedro</surname> <given-names>R.</given-names>
</name>
<name>
<surname>MacLean</surname> <given-names>R. C.</given-names>
</name>
<name>
<surname>San Mill&#xe1;n</surname> <given-names>&#xc1;.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Beyond horizontal gene transfer: the role of plasmids in bacterial evolution</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>19</volume>, <fpage>347</fpage>&#x2013;<lpage>359</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41579-020-00497-1</pub-id>, PMID: <pub-id pub-id-type="pmid">33469168</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silistre</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Raoux-Barbot</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Mancinelli</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Sangouard</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Dupin</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Belyy</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Prevalence of exoY activity in <italic>pseudomonas aeruginosa</italic> reference panel strains and impact on cytotoxicity in epithelial cells</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>, <elocation-id>666097</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.666097</pub-id>, PMID: <pub-id pub-id-type="pmid">34675890</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>J. M.</given-names>
</name>
<name>
<surname>Long</surname> <given-names>H. B.</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>B. R.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>He</surname> <given-names>H. C.</given-names>
</name>
<etal/>
</person-group>. (<year>2024</year>). <article-title>Genomic characterization of a bla (KPC-2)-producing IncM2 plasmid harboring transposon &#x394;Tn<italic>6296</italic> in Klebsiella michiganensis</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>14</volume>, <elocation-id>1492700</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2024.1492700</pub-id>, PMID: <pub-id pub-id-type="pmid">39600872</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>W.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>Genetic characterization of a novel <italic>bla</italic>
<sub>DIM-2</sub>-carrying megaplasmid p12969-DIM from clinical Pseudomonas putida</article-title>. <source>J. Antimicrob. Chemother.</source> <volume>71</volume>, <fpage>909</fpage>&#x2013;<lpage>912</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/jac/dkv426</pub-id>, PMID: <pub-id pub-id-type="pmid">26679251</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thrane</surname> <given-names>S. W.</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>V. L.</given-names>
</name>
<name>
<surname>Freschi</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Kukavica-Ibrulj</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Boyle</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Laroche</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>The Widespread Multidrug-Resistant Serotype O12 <italic>Pseudomonas aeruginosa</italic> Clone Emerged through Concomitant Horizontal Transfer of Serotype Antigen and Antibiotic Resistance Gene Clusters</article-title>. <source>mBio</source> <volume>6</volume>, <fpage>e01396</fpage>&#x2013;<lpage>e01315</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/mBio.01396-15</pub-id>, PMID: <pub-id pub-id-type="pmid">26396243</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Varani</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Siguier</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Gourbeyre</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Charneau</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Chandler</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>ISsaga is an ensemble of web-based methods for high throughput identification and semi-automatic annotation of insertion sequences in prokaryotic genomes</article-title>. <source>Genome Biol.</source> <volume>12</volume>, <fpage>R30</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/gb-2011-12-3-r30</pub-id>, PMID: <pub-id pub-id-type="pmid">21443786</pub-id></citation></ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>Y. L.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y. K.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>D. K.</given-names>
</name>
<name>
<surname>He</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Yao</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Functions of sphingolipids in pathogenesis during host-pathogen interactions</article-title>. <source>Front. Microbiol.</source> <volume>12</volume>, <elocation-id>701041</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2021.701041</pub-id>, PMID: <pub-id pub-id-type="pmid">34408731</pub-id></citation></ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yigit</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Queenan</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>G. J.</given-names>
</name>
<name>
<surname>Domenech-Sanchez</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Biddle</surname> <given-names>J. W.</given-names>
</name>
<name>
<surname>Steward</surname> <given-names>C. D.</given-names>
</name>
<etal/>
</person-group>. (<year>2001</year>). <article-title>Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae</article-title>. <source>Antimicrob. Agents Chemother.</source> <volume>45</volume>, <fpage>1151</fpage>&#x2013;<lpage>1161</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.45.4.1151-1161.2001</pub-id>, PMID: <pub-id pub-id-type="pmid">11257029</pub-id></citation></ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoon</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Ha</surname> <given-names>S. M.</given-names>
</name>
<name>
<surname>Lim</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Chun</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A large-scale evaluation of algorithms to calculate average nucleotide identity</article-title>. <source>Antonie Van Leeuwenhoek</source> <volume>110</volume>, <fpage>1281</fpage>&#x2013;<lpage>1286</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s10482-017-0844-4</pub-id>, PMID: <pub-id pub-id-type="pmid">28204908</pub-id></citation></ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname> <given-names>D. F.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Z. F.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>P. D.</given-names>
</name>
<name>
<surname>Qu</surname> <given-names>P. H.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Characterization of carbapenem-resistant Acinetobacter baumannii ST540 and <italic>Klebsiella pneumoniae</italic> ST2237 isolates in a pneumonia case from China</article-title>. <source>J. Appl. Microbiol.</source> <volume>133</volume>, <fpage>1434</fpage>&#x2013;<lpage>1445</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jam.15648</pub-id>, PMID: <pub-id pub-id-type="pmid">35652720</pub-id></citation></ref>
</ref-list>
</back>
</article>